Ablynx is granted GLP certificate for new GLP unit

07-28-2011: Ablynx announced that it has been granted a Certificate of Good Laboratory Practise (GLP) from the Belgian Scientific Institute of Public Health (IPH) for its new GLP unit at its headquarters in Ghent, Belgium, after having been inspected in May 2011.

Having received this GLP certificate, Ablynx's GLP unit will be able to seamlessly carry out pre-clinical analytical testing and pharmacokinetics studies in-house, to the required regulatory standard.

Dr Edwin Moses, CEO and Chairman of Ablynx, commented: "Being awarded the GLP certificate from the Belgian authorities confirms our commitment to consistently perform at a high standard in this stringent regulatory environment. This is an important milestone for Ablynx as we continue to grow towards a product-based company. With this certificate, we no longer solely rely on third parties to carry out the pre-clinical GLP testing for our programmes. This enables us to retain more control on quality, timing and associated costs."